Medpace Holdings, Inc.
MEDP- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001668397
In the last 90 days, Medpace Holdings, Inc. insiders filed 0 open-market purchases and 20 sales; 700 institutions reported holding it in 13F filings for Q2 2026, worth $13.1B in total; superinvestors Giverny Capital and Fundsmith hold it.
Q4 2025 vs. Q3 2025
How the institutions holding Medpace Holdings, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 673 | 13 | 788 | +128 |
| Shares | 24.0M | 143.2K | 23.8M | −57.8K (−0.2%) |
| Value | $12.3B | $73.6M | $13.4B | +$1.11B (+9.0%) |
13 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (181)
Institutions that held Medpace Holdings, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Showing the largest 100 of 181 by value.
Sold out (53)
Institutions that held Medpace Holdings, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
Not filed for Q4 2025 yet (13)
Institutions that held Medpace Holdings, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Bares Capital Management, Inc. | 111,507 | $57.3M |
| AXA Investment Managers S.A. | 19,186 | $9.86M |
| Glenmede Investment Management, LP | 4,748 | $2.44M |
| Pinebridge Investments, L.P. | 2,766 | $1.42M |
| Lindenwold Advisors | 1,491 | $766.6K |
| Optimum Investment Advisors | 1,050 | $539.9K |
| Full Sail Capital, LLC | 881 | $453.0K |
| Corton Capital Inc. | 535 | $275.1K |
| Shell Asset Management Co | 492 | $253.0K |
| Gries Financial LLC | 450 | $231.4K |
| AllSquare Wealth Management LLC | 100 | $51.4K |
| Hemington Wealth Management | 30 | $15.0K |
| Binnacle Investments Inc | 5 | $2.57K |